View Post

Varian Unveils Innovative New Solution for Adaptive Therapy

In Clinical Trials by Barbara Jacoby

Source: PR Newswire From: yahoo.com Key Highlights – Ethos therapy provides an opportunity to transform cancer care – Represents the first artificial intelligence (AI)-powered personalized cancer care delivery system in radiation oncology* – Utilizes multi-modality images (MR, PET, CT) and daily iterative CBCT imaging to help clinicians assess anatomical changes and adapt the treatment plan while patient is on the …

View Post

NRG Oncology Approves Danbury and Norwalk Hospitals as Primary Sites for Clinical Research

In Clinical Trials by Barbara Jacoby

·         Danbury Hospital and Norwalk Hospital received approval to join NRG Oncology as primary clinical research sites. This means that patients at Danbury Hospital and Norwalk Hospital now have expanded access to the latest clinical trials for breast cancer, radiation oncology, and gynecologic cancer. ·         Through NRG Oncology clinical trials, Danbury Hospital and Norwalk Hospital patients can receive the most …

View Post

NANOBIOTIX: NEW TRANSLATIONAL DATA PRESENTED AT ASTRO, NCI AND SITC’S IMMUNOTHERAPY WORKSHOP

In In The News by Barbara Jacoby

·         Translational data showing tumor immune activity and positive Tumor Infiltrating Lymphocytes (TILs) in human and mouse model ·         Confirmation of the ability to transform “cold” tumors into “hot” tumors and that NBTXR3 treatment may have an impact on the tumor microenvironment ·         Opening up of the potential for NBTXR3 to treat metastases NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a …

ViewRay™ Announces World’s First Patients Treated Using MRI-Guided Radiation Therapy

In In The News by Barbara Jacoby

The ViewRay™ system, the world’s first and only MRI-guided radiation therapy system, is being used to treat patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Mo. The ViewRay system provides a patented combination of simultaneous radiation therapy delivery and continuous magnetic resonance imaging (MRI) for the treatment of cancer. MRI-guided radiation …

Letter from the Metastatic Breast Cancer Network

In In The News by Barbara Jacoby

By: Shirley Mertz, President For those of us who live with metastatic breast cancer, research does not move fast enough.  While patients focus on wanting more new, systemic therapies to stabilize our disease, we may not realize that some researchers and clinicians are looking at attacking metastatic disease using different approaches. One such approach was discussed at MBCN’s 2012 Metastatic …

New Breast Cancer Surgical Guideline Offers Cost- and Life-Improving Recommendations

In In The News by Barbara Jacoby

The Society of Surgical Oncology (SSO) is proud to announce the release of a comprehensive consensus guideline for physicians treating breast cancer that will reduce healthcare costs and improve the course of treatment. Developed in conjunction with the American Society of Radiation Oncology (ASTRO), it outlines an evidence-based surgical treatment path that will save patients from unnecessary surgery. “A significant …

Extended outcomes of adjuvant accelerated partial breast irradiation patients show excellent tumor control, breast cosmesis and minimal late toxicity

In In The News by Barbara Jacoby

From: astro.org Long-term (five-year) outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation (APBI) after breast-conserving surgery show excellent tumor control and breast cosmesis (cosmetic outcomes) with minimal late toxicity, according to a study published in the February 1, 2014 print edition of the International Journal of Radiation Oncology ● Biology ● Physics (Red Journal), the official scientific …